288 related articles for article (PubMed ID: 28964592)
1. Interleukin 7 receptor alpha Thr244Ile genetic polymorphism is associated with susceptibility and prognostic markers in breast cancer subgroups.
Vitiello GAF; Losi Guembarovski R; Amarante MK; Ceribelli JR; Carmelo ECB; Watanabe MAE
Cytokine; 2018 Mar; 103():121-126. PubMed ID: 28964592
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis.
Vitiello GAF; Guembarovski RL; Hirata BKB; Amarante MK; de Oliveira CEC; de Oliveira KB; Cebinelli GCM; Guembarovski AL; Campos CZ; Watanabe MAE
J Cancer Res Clin Oncol; 2018 Apr; 144(4):645-655. PubMed ID: 29362917
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes.
Vitiello GAF; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
Breast Cancer Res Treat; 2019 Nov; 178(1):207-219. PubMed ID: 31364002
[TBL] [Abstract][Full Text] [Related]
4. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
5. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
6. Involvement of INF-γ functional single nucleotide polymorphism +874 T/A (rs2430561) in breast cancer risk.
Al-Rashidi HE; Refaat S; Ahmed E; Hussein DT; Eltantawy FM; Hamed S
Saudi J Biol Sci; 2021 Nov; 28(11):6289-6296. PubMed ID: 34759748
[TBL] [Abstract][Full Text] [Related]
7. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.
Bayram S; Sümbül AT; Dadaş E
Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852
[TBL] [Abstract][Full Text] [Related]
8. Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort.
Vitiello GAF; de Sousa Pereira N; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1523-1532. PubMed ID: 32285256
[TBL] [Abstract][Full Text] [Related]
9. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferases deletions may act as prognosis and therapeutic markers in breast cancer.
Campos CZ; Losi Guembarovski R; de Oliveira CEC; Banin Hirata BK; Vitiello GAF; Dias FL; Hiroki CH; Watanabe MAE; Mazzuco TL
Clin Exp Med; 2018 Feb; 18(1):27-35. PubMed ID: 28455582
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk.
Wang Z; Liu QL; Sun W; Yang CJ; Tang L; Zhang X; Zhong XM
Croat Med J; 2014 Dec; 55(6):638-46. PubMed ID: 25559835
[TBL] [Abstract][Full Text] [Related]
12. Investigating the exon 6 sequence changes of interleukin 7 receptor A (IL7RA) gene in patients with relapsing-remitting multiple sclerosis.
Taheri M; Sayad A
Hum Antibodies; 2018 Feb; 26(2):43-48. PubMed ID: 28582853
[TBL] [Abstract][Full Text] [Related]
13.
Groheux D; Martineau A; Teixeira L; Espié M; de Cremoux P; Bertheau P; Merlet P; Lemarignier C
Breast Cancer Res; 2017 Jan; 19(1):3. PubMed ID: 28057031
[TBL] [Abstract][Full Text] [Related]
14. CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer.
Guembarovski AL; Guembarovski RL; Hirata BKB; Vitiello GAF; Suzuki KM; Enokida MT; Watanabe MAE; Reiche EMV
Mol Biol Rep; 2018 Oct; 45(5):741-750. PubMed ID: 29926386
[TBL] [Abstract][Full Text] [Related]
15.
Banin Hirata BK; Losi Guembarovski R; Vitiello GAF; Guembarovski AL; Brajão de Oliveira K; Watanabe MAE
Dis Markers; 2017; 2017():6359603. PubMed ID: 28713192
[No Abstract] [Full Text] [Related]
16. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
[TBL] [Abstract][Full Text] [Related]
17. Correlations of
Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
[TBL] [Abstract][Full Text] [Related]
18. Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness.
Snoussi K; Mahfoudh W; Bouaouina N; Fekih M; Khairi H; Helal AN; Chouchane L
BMC Cancer; 2010 Jun; 10():283. PubMed ID: 20540789
[TBL] [Abstract][Full Text] [Related]
19. Functional SNP in stem of mir-146a affects Her2 status and breast cancer survival.
Meshkat M; Tanha HM; Naeini MM; Ghaedi K; Sanati MH; Meshkat M; Bagheri F
Cancer Biomark; 2016 Jul; 17(2):213-22. PubMed ID: 27434289
[TBL] [Abstract][Full Text] [Related]
20. HER2 Ile655Val polymorphism is negatively associated with breast cancer susceptibility.
de Almeida FC; Banin Hirata BK; Ariza CB; Losi Guembarovski R; de Oliveira KB; Suzuki KM; Guembarovski AL; Oda JMM; Vitiello GAF; Watanabe MAE
J Clin Lab Anal; 2018 Jul; 32(6):e22406. PubMed ID: 29417620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
